INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 211 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,784,576 | -14.5% | 149,445 | +4.0% | 0.01% | 0.0% |
| Q2 2023 | $9,100,908 | +17.5% | 143,729 | +0.4% | 0.01% | 0.0% |
| Q1 2023 | $7,748,634 | +1.1% | 143,096 | -1.2% | 0.01% | 0.0% |
| Q4 2022 | $7,668,002 | +0.4% | 144,898 | -11.7% | 0.01% | -12.5% |
| Q3 2022 | $7,637,000 | -10.6% | 164,132 | +9.7% | 0.01% | 0.0% |
| Q2 2022 | $8,539,000 | -6.3% | 149,600 | +0.4% | 0.01% | 0.0% |
| Q1 2022 | $9,116,000 | +24.6% | 148,976 | +6.6% | 0.01% | +33.3% |
| Q4 2021 | $7,314,000 | +46.4% | 139,743 | +4.3% | 0.01% | +50.0% |
| Q3 2021 | $4,995,000 | +7.8% | 133,982 | +18.0% | 0.00% | 0.0% |
| Q2 2021 | $4,635,000 | +64.1% | 113,548 | +36.4% | 0.00% | +33.3% |
| Q1 2021 | $2,824,000 | +7.8% | 83,229 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $2,619,000 | -34.4% | 82,349 | -47.0% | 0.00% | -40.0% |
| Q3 2020 | $3,990,000 | -5.8% | 155,514 | -5.8% | 0.01% | -16.7% |
| Q2 2020 | $4,237,000 | +107.5% | 165,062 | +24.2% | 0.01% | +100.0% |
| Q1 2020 | $2,042,000 | -56.0% | 132,853 | -1.7% | 0.00% | -50.0% |
| Q4 2019 | $4,639,000 | +586.2% | 135,200 | +49.3% | 0.01% | +500.0% |
| Q3 2019 | $676,000 | -38.3% | 90,545 | +7.2% | 0.00% | -50.0% |
| Q2 2019 | $1,096,000 | +31.1% | 84,450 | +23.0% | 0.00% | +100.0% |
| Q1 2019 | $836,000 | +121.2% | 68,650 | +106.9% | 0.00% | 0.0% |
| Q4 2018 | $378,000 | -75.4% | 33,174 | -53.1% | 0.00% | -50.0% |
| Q3 2018 | $1,536,000 | +35.4% | 70,800 | +10.4% | 0.00% | 0.0% |
| Q2 2018 | $1,134,000 | +11.7% | 64,150 | +33.0% | 0.00% | 0.0% |
| Q1 2018 | $1,015,000 | +328.3% | 48,232 | +195.0% | 0.00% | – |
| Q4 2017 | $237,000 | – | 16,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |